Two Nations Approve Sale of ICN’s Ribavirin:...
- Share via
From Times Staff and Wire Reports
Two Nations Approve Sale of ICN’s Ribavirin: ICN Pharmaceuticals Inc. said that Hungary and New Zealand have authorized the sale of ribavirin, which the Costa Mesa firm markets under the Virazole label, for treatment of infant lung disease caused by respiratory syncytial virus (RSV). The company said Virazole is now authorized for use against RSV in 18 countries, including the United States.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
